Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* Emergency-use approval for Bharat's COVAXIN* Government also approved use of AstraZeneca/Oxford vaccine* AstraZeneca/Oxford shot to lead immunisation programmeBy Krishna N. DasNEW DELHI, Jan 3 (Reuters) - India on Sunday granted emergency approval...
Read more* COVID-19 cases at record levels in UK, and rising* Children should attend school where permitted - PM* Vaccine delivery set to accelerate on Monday (Adds Labour Party leader calling for national lockdown)By William JamesLONDON, Jan 3 (Reuters) - B...
Read more* COVID-19 cases at record levels in UK, and rising* Children should attend school where permitted - PM* Vaccine delivery set to accelerate on Monday (Adds latest data)By William JamesLONDON, Jan 3 (Reuters) - British Prime Minister Boris Johnson s...
Read more* COVID-19 cases at record levels in UK, and rising* Children should attend school where permitted - PM* Vaccine delivery set to accelerate on Monday (Adds Scottish parliament recall)By William JamesLONDON, Jan 3 (Reuters) - British Prime Minister B...
Read more* COVID-19 cases at record levels in UK, and rising* Children should attend school where permitted - PM* Vaccine delivery set to accelerate on Monday (Adds vaccine comments)By William JamesLONDON, Jan 3 (Reuters) - British Prime Minister Boris John...
Read more
Schools Are Safe And Children Should Return This Week, Says UK PM
Read moreLONDON, Jan 3 (Reuters) - Britain will have 530,000 doses of the Oxford/AstraZeneca COVID-19 vaccine ready to administer on Monday and hopes to provide "tens of millions" of vaccinations over the next three months, Prime Minister Boris Johnson sa...
Read moreLONDON, Jan 3 (Reuters) - British Prime Minister Boris Johnson said on Sunday schools were safe, and advised parents to send their children in, in areas where rules allow it, responding to concerns about the surge in COVID-19 cases as classes are...
Read more* AstraZeneca's COVISHIELD, Bharat Biotech's COVAXIN approved* COVISHIELD found 70.42% effective in studies overseas* COVAXIN "safe and provides a robust immune response"- regulator* No efficacy data provided for COVAXIN (Adds comments from local ...
Read more(Adds details)By Aftab Ahmed and Nigam PrustyNEW DELHI, Jan 3 (Reuters) - India's drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by ...
Read more* AstraZeneca's COVISHIELD, Bharat Biotech's COVAXIN approved* COVISHIELD found 70.42% effective* COVAXIN "safe and provides a robust immune response"-regulator* No efficacy data provided for COVAXIN (Adds comments from health minister, Bharat Bio...
Read more* AstraZeneca's COVISHIELD, Bharat Biotech's COVAXIN approved* COVISHIELD found 70.42% effective* COVAXIN "safe and provides a robust immune response"-regulator* No efficacy data provided for COVAXIN (Adds details)By Aftab Ahmed and Krishna N. Das...
Read more(Adds details)By Aftab Ahmed and Nigam PrustyNEW DELHI, Jan 3 (Reuters) - The head of India's drugs regulator said on Sunday he had given final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford Uni...
Read moreNEW DELHI, Jan 3 (Reuters) - India's drugs regulator said on Sunday it had given final emergency-use approval for two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech. (Reporti...
Read moreBy Sudarshan Varadhan and Krishna N. DasCHENNAI/NEW DELHI, Jan 2 (Reuters) - India's drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZen...
Read more
Last checked at